Pathfinders in Biopharma

By: RBC Capital Markets
Listen for free

  • Summary

  • Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
    Copyright 2024 RBC Capital Markets
    Show more Show less
Business & Careers Economics Personal Finance Politics & Government
Show more Show less
Episodes
  • Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments

    Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments
    Nov 22 2024

    Innovation is surging in the U.S biotechnology sector, so why are investors still fearful about committing? Noël Brown, Head of U.S. Biotechnology Investment Banking at RBC Capital Markets, is joined by fund founders Craig Gordon, MD, CEO and CIO at GordonMD® Global Investments LP and Srini Akkaraju, MD, PhD, Managing Partner at Samsara BioCapital, to analyze the prospects for a full return of capital to the sector.
    Show more Show less
    23 mins
  • Former Investor Who Chose Broadcasting Over Biotech ETFs

    Former Investor Who Chose Broadcasting Over Biotech ETFs
    Sep 30 2024

    Former biotech investor, Brad Loncar has pivoted his career from investing to reporting on the industry. Instead of serving the biotech bubble, he hopes to reach a wide audience with interest in science. Loncar explains why he switched careers and sets out his ambitions for his channel, Biotech TV.
    Show more Show less
    12 mins
  • Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?

    Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?
    Aug 29 2024

    The hardest parts of drug discovery will be vastly simplified if the mysteries of molecules and proteins can be cracked. That may be beyond human capabilities – but AI is working hard on it. In this episode of RBC’s Pathfinders in Biopharma, Noël Brown is joined by Clarissa Desjardins, CEO of Congruence, and Laksh Aithani, CEO and Co-founder of Charm Therapeutics, to discuss how far the tech can take us.
    Show more Show less
    34 mins

What listeners say about Pathfinders in Biopharma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available